These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7850746)

  • 1. Involvement of natural killer cells in chronic myeloid leukemia.
    Knuutila S; Larramendy ML; Ruutu T; Helander T
    Cancer Genet Cytogenet; 1995 Jan; 79(1):21-4. PubMed ID: 7850746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The BCR/ABL transgene causes abnormal NK cell differentiation and can be found in circulating NK cells of advanced phase chronic myelogenous leukemia patients.
    Nakajima H; Zhao R; Lund TC; Ward J; Dolan M; Hirsch B; Miller JS
    J Immunol; 2002 Jan; 168(2):643-50. PubMed ID: 11777957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloid/natural killer cell precursor blast crisis of chronic myelogenous leukemia with two Philadelphia (Ph-1) chromosomes.
    Kahl C; Pelz AF; Bartsch R; Jentsch-Ullrich K; Brückner R; Fostitsch HP; Franke A
    Ann Hematol; 2001 Jan; 80(1):58-61. PubMed ID: 11233779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The morphological, immunophenotypical and cytogenetic characteristics study of blast crisis in chronic myeloid leukemia].
    Tang X; Wu D; Xue Y; Zhu M; Lu D; Ruan C
    Zhonghua Nei Ke Za Zhi; 2002 Oct; 41(10):685-7. PubMed ID: 12485536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myeloid/natural killer cell blast crisis representing an additional translocation, t(3;7)(q26;q21) in Philadelphia-positive chronic myelogenous leukemia.
    Henzan H; Yoshimoto G; Okeda A; Nagasaki Y; Hirano G; Takase K; Tanimoto T; Miyamoto T; Fukuda T; Nagafuji K; Harada M
    Ann Hematol; 2004 Dec; 83(12):784-8. PubMed ID: 15322764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blast crisis of chronic myelogenous leukemia exhibiting immunophenotypic features of a myeloid/natural killer cell precursor.
    Murase T; Suzuki R; Tashiro K; Morishima Y; Nakamura S
    Int J Hematol; 1999 Feb; 69(2):89-91. PubMed ID: 10071456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorescence in situ hybridization (FISH) detection of trisomy 8 in myeloid cells in chronic myeloid leukemia (CML): a study of archival blood and bone marrow smears.
    Nguyen PL; Arthur DC; Litz CE; Brunning RD
    Leukemia; 1994 Oct; 8(10):1654-62. PubMed ID: 7934161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mixed phenotype (T/B/myeloid) extramedullary blast crisis as an initial presentation of chronic myelogenous leukemia.
    Qing X; Qing A; Ji P; French SW; Mason H
    Exp Mol Pathol; 2018 Apr; 104(2):130-133. PubMed ID: 29501750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression.
    Lee DS; Lee YS; Yun YS; Kim YR; Jeong SS; Lee YK; She CJ; Yoon SS; Shin HR; Kim Y; Cho HI
    Genes Chromosomes Cancer; 2003 Jul; 37(3):291-9. PubMed ID: 12759927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced NK activity during blast crisis in chronic myelogenous leukemia (CML).
    Delwail V; Meseri A; Brizard A; Lecron JC; Sadoun A; Costerousse F; Guilhot F; Tanzer J; Goube de Laforest P
    Leuk Res; 1992; 16(6-7):721-2. PubMed ID: 1635387
    [No Abstract]   [Full Text] [Related]  

  • 11. No correlation between locations of bcr breakpoints and clinical states in Ph1-positive CML patients.
    Ogawa H; Sugiyama H; Soma T; Masaoka T; Kishimoto S
    Leukemia; 1989 Jul; 3(7):492-6. PubMed ID: 2733454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphoid blast crisis in a patient with Philadelphia-chromosome-negative chronic myelocytic leukemia.
    Takahira H; Shibata K; Hirata J; Umemura T; Nishimura J; Nawata H
    Acta Haematol; 1989; 81(3):155-9. PubMed ID: 2496564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural killer lymphocyte blast crisis of chronic myelogenous leukemia.
    Warzynski MJ; White C; Golightly MG; Steingart R; Otto RN; Podgurski AE; Johnson ML; Glynn P; Smith DE
    Am J Hematol; 1989 Dec; 32(4):279-86. PubMed ID: 2816923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia or Chronic Myeloid Leukemia in Lymphoid Blast Crisis.
    Kolenova A; Maloney KW; Hunger SP
    J Pediatr Hematol Oncol; 2016 Aug; 38(6):e193-5. PubMed ID: 27164534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromosomal characteristics of Ph-positive chronic myelogenous leukemia in transformation. A study of 23 Chinese patients in Taiwan.
    Tien HF; Chuang SM; Wang CH; Lee FY; Chien SH; Chen YC; Shen MC; Liu CH
    Cancer Genet Cytogenet; 1989 May; 39(1):89-97. PubMed ID: 2731152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lineage involvement by BCR/ABL in Ph+ lymphoblastic leukemias: chronic myelogenous leukemia presenting in lymphoid blast vs Ph+ acute lymphoblastic leukemia.
    Anastasi J; Feng J; Dickstein JI; Le Beau MM; Rubin CM; Larson RA; Rowley JD; Vardiman JW
    Leukemia; 1996 May; 10(5):795-802. PubMed ID: 8656674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoglobulin and T cell receptor gene rearrangements in Philadelphia chromosome-positive leukemia: a different involvement pattern in blast crisis and acute leukemia.
    Ohyashiki JH; Ohyashiki K; Tauchi T; Saito M; Nakazawa S; Kimura N; Toyama K
    Leukemia; 1990 Aug; 4(8):572-9. PubMed ID: 2143795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Differential analysis of BM cell morphology, immunophenotypic, cytogenetic characters and prognosis between myeloblastic and lymphoblastic crisis of CML].
    Liu YL; Wang XN; Liu HS
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):629-33. PubMed ID: 24989266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous presence of major secondary chromosomal abnormalities in blast crisis of chronic myeloid leukemia.
    Lu CM; Wang E; Lawrence HJ
    Cancer Genet Cytogenet; 2007 Jan; 172(2):174-5. PubMed ID: 17213030
    [No Abstract]   [Full Text] [Related]  

  • 20. Chronic myelogenous leukemia: mechanisms underlying disease progression.
    Shet AS; Jahagirdar BN; Verfaillie CM
    Leukemia; 2002 Aug; 16(8):1402-11. PubMed ID: 12145676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.